GlassScriptPhysician profile
Sydney Leslie
NPI 1669934931
$2,657.12
in general payments reported to CMS, 2019-2025
20 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $769 · 2023: $397 · 2024: $638 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $675.66 | 2022-2025 | |
| Galderma Laboratories, L.P. | $324.16 | 2021-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $302.14 | 2022-2023 | Dupixent |
| Arcutis Biotherapeutics, INC. | $210.34 | 2023-2024 | Zoryve |
| Journey Medical Corporation | $208.07 | 2022-2025 | |
| Pfizer INC. | $205.21 | 2022-2025 | |
| Incyte Corporation | $153.41 | 2022-2023 | Opzelura |
| Genzyme Corporation | $88.66 | 2022-2025 | |
| Amgen INC. | $81.09 | 2021-2024 | Otezla |
| Sanofi-Aventis U.S. LLC | $79.99 | 2022 | |
| Smith+Nephew, INC. | $50.00 | 2025 | Grafix Pl |
| Ucb, INC. | $45.94 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $44.67 | 2023-2025 | Winlevi, Absorica Ld |
| Organogenesis INC. | $43.06 | 2024 | |
| Novartis Pharmaceuticals Corporation | $33.30 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $26.04 | 2022-2024 | |
| Leo Pharma INC. | $25.21 | 2025 | Anzupgo |
| Strata Skin Sciences, INC. | $21.07 | 2025 | Xtrac |
| Becton, Dickinson and Company | $20.20 | 2024 | Venclose Maven Catheter |
| Lnhc, INC | $18.90 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Leslie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.